UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

247 Early Growth and Development of Container-grown Pawpaw Seedlings in Various Potting Media and Nutrient Regimes

HortScience, 2000-06, Vol.35 (3), p.433-433

2000

Volltextzugriff (PDF)

342 Shading Influences the Growth and Development of Pawpaw Seedlings Grown Outside

HortScience, 1999-06, Vol.34 (3), p.502-502

1999

Volltextzugriff (PDF)

5-fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma

Gynecologic oncology, 1992-09, Vol.46 (3), p.326-329

1992

Volltextzugriff (PDF)

9-Î²-d-Arabinofuranosyl-2-fluoroadenine Inhibits Expression of Vascular Endothelial Growth Factor through Hypoxia-Inducible Factor-1 in Human Ovarian Cancer Cells

Molecular pharmacology, 2004-07, Vol.66 (1), p.178

2004

Volltextzugriff (PDF)

9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells

Molecular pharmacology, 2004-07, Vol.66 (1), p.178-186

2004

Volltextzugriff (PDF)

The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor

Anti-cancer drugs, 1993-04, Vol.4 (2), p.141-148

1993

Volltextzugriff (PDF)

Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues

Cancer letters, 2000-04, Vol.151 (2), p.127-132

2000

Volltextzugriff (PDF)

Abstract 2156: c-Myb promotes growth, invasion and androgen-independence of prostate cancer cells

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2156-2156

2011

Volltextzugriff (PDF)

Abstract 249: Inhibition of protein phosphatase 2A supports androgen-independent growth of prostate cancer cells

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.249-249

2011

Volltextzugriff (PDF)

Abstract 3406: Understanding molecular pathway differences between ovarian cancer stem cells (OCSC) and non-ovarian cancer stem cells (non-OCSC) leads to the Hedgehog pathway as a common thread

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.3406-3406

2011

Volltextzugriff (PDF)

Abstract 3991: Protein phosphatase 2A (PP2A) downregulation is associated with androgen-independent and aggressive phenotypes in prostate cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3991-3991

2012

Volltextzugriff (PDF)

Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.5571-5571

2013

Volltextzugriff (PDF)

Abstract 5613: A specific isoform of Gli1 binds the Gli-binding site of the c-jun and c-fos promoters

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5613-5613

2012

Volltextzugriff (PDF)

Abstract 605: Olive polyphenol, hydroxytyrosol, exerts anti-tumor effects in prostate cancer cells by targeting Akt, STAT3 and AR signaling

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.605-605

2012

Volltextzugriff (PDF)

Abstract 771: Changes in the subcellular pharmacology of cisplatin, in response to treatment of cells with an anti-Gli1 shRNA

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.771-771

2012

Volltextzugriff (PDF)

Abstract 834: Inhibition of Gli1 results in altered c-jun activation, inhibition of cisplatin-induced up-regulation of ERCC1, XPD, and XRCC1, and inhibition of platinum-DNA adduct repair

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.834-834

2012

Volltextzugriff (PDF)

Abstract CN4-3: Factors that influence the regulation of ERCC1 in drug-resistant cells

Clinical cancer research, 2010-04, Vol.16 (7_Supplement), p.CN4-3-CN4-3

2010

Volltextzugriff (PDF)

Abstract LB-223: A specific Isoform of Gli1 binds the promoter region of c-fos in A2780-CP70 human ovarian cancer cells

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.LB-223-LB-223

2013

Volltextzugriff (PDF)

Abstract LB-281: Inhibition of Hedgehog results in altered regulation of c-jun and of ERCC1 in cisplatin-resistant A2780-CP70 human ovarian cancer cells

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.LB-281-LB-281

2010

Volltextzugriff (PDF)

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

The Journal of clinical investigation, 1991-03, Vol.87 (3), p.772-777

1991

Volltextzugriff (PDF)

Acute Leukemia Following Cisplatin-Based Chemotherapy in a Patient With Ovarian Cancer

JNCI : Journal of the National Cancer Institute, 1990-03, Vol.82 (5), p.431-432

1990

Volltextzugriff (PDF)

Acute renal toxicity associated with suramin in the treatment of prostate cancer

Cancer, 1994-09, Vol.74 (5), p.1612-1614

1994

Volltextzugriff (PDF)

Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines

Cancer gene therapy, 2002-01, Vol.9 (1), p.62-70

2002

Volltextzugriff (PDF)

Adult relationship -building practices experienced by students in a reorganized school

Reed, Eddie

2006

Volltextzugriff (PDF)

Age does not influence taxol dose intensity in recurrent carcinoma of the ovary

Cancer, 1993-01, Vol.71 (S2), p.594-600

1993

Volltextzugriff (PDF)

1 – 25 von 287

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(252)
Mit Volltextzugriff
(236)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

247 Early Growth and Development of Container-grown Pawpaw Seedlings in Various Potting Media and Nutrient Regimes

342 Shading Influences the Growth and Development of Pawpaw Seedlings Grown Outside

5-fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma

9-Î²-d-Arabinofuranosyl-2-fluoroadenine Inhibits Expression of Vascular Endothelial Growth Factor through Hypoxia-Inducible Factor-1 in Human Ovarian Cancer Cells

9-beta-D-arabinofuranosyl-2-fluoroadenine inhibits expression of vascular endothelial growth factor through hypoxia-inducible factor-1 in human ovarian cancer cells

The absence of cumulative bone marrow toxicity in patients with recurrent adenocarcinoma of the ovary receiving dose-intense taxol and granulocyte colony stimulating factor

Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues

Abstract 2156: c-Myb promotes growth, invasion and androgen-independence of prostate cancer cells

Abstract 249: Inhibition of protein phosphatase 2A supports androgen-independent growth of prostate cancer cells

Abstract 3406: Understanding molecular pathway differences between ovarian cancer stem cells (OCSC) and non-ovarian cancer stem cells (non-OCSC) leads to the Hedgehog pathway as a common thread

Abstract 3991: Protein phosphatase 2A (PP2A) downregulation is associated with androgen-independent and aggressive phenotypes in prostate cancer

Abstract 5571: Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer

Abstract 5613: A specific isoform of Gli1 binds the Gli-binding site of the c-jun and c-fos promoters

Abstract 605: Olive polyphenol, hydroxytyrosol, exerts anti-tumor effects in prostate cancer cells by targeting Akt, STAT3 and AR signaling

Abstract 771: Changes in the subcellular pharmacology of cisplatin, in response to treatment of cells with an anti-Gli1 shRNA

Abstract 834: Inhibition of Gli1 results in altered c-jun activation, inhibition of cisplatin-induced up-regulation of ERCC1, XPD, and XRCC1, and inhibition of platinum-DNA adduct repair

Abstract CN4-3: Factors that influence the regulation of ERCC1 in drug-resistant cells

Abstract LB-223: A specific Isoform of Gli1 binds the promoter region of c-fos in A2780-CP70 human ovarian cancer cells

Abstract LB-281: Inhibition of Hedgehog results in altered regulation of c-jun and of ERCC1 in cisplatin-resistant A2780-CP70 human ovarian cancer cells

Acquired cisplatin resistance in human ovarian cancer cells is associated with enhanced repair of cisplatin-DNA lesions and reduced drug accumulation

Acute Leukemia Following Cisplatin-Based Chemotherapy in a Patient With Ovarian Cancer

Acute renal toxicity associated with suramin in the treatment of prostate cancer

Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines

Adult relationship -building practices experienced by students in a reorganized school

Age does not influence taxol dose intensity in recurrent carcinoma of the ovary

Suchergebnisse filtern